Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2010
Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active effluxSagar Agarwal, Ramola Sane, Jose L Gallardo, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 28, 2012
Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of gliomaSagar Agarwal, Pooja Manchanda, Michael A Vogelbaum, et al.Journal of Neurosurgery|February 8, 2011
Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brainSeunguk Oh, Alexander K Tsai, John R Ohlfest, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 23, 2013
CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancerSuresh Kumar Swaminathan, Emilie Roger, Udaya Toti, et al.Journal of Neuro-Oncology|September 11, 2010
A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculatureAlexander K Tsai, Seunguk Oh, Hua Chen, et al.ACS Medicinal Chemistry Letters|July 28, 2012
Discovery of Imidazoquinolines with Toll-Like Receptor 7/8 Independent Cytokine InductionCe Shi, Zhengming Xiong, Padmaja Chittepu, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2015
Parthenolide prodrug LC-1 slows growth of intracranial gliomaJoseph K Hexum, Chani M Becker, Aaron M Kempema, et al.Journal of Medicinal Chemistry|January 4, 2014
Structure-activity relationship analysis of imidazoquinolines with Toll-like receptors 7 and 8 selectivity and enhanced cytokine inductionCharles E Schiaffo, Ce Shi, Zhengming Xiong, et al.Journal of Immunological Methods|August 3, 2010
Identification of a novel monoclonal antibody recognizing CD133Suresh Kumar Swaminathan, Michael R Olin, Colleen L Forster, et al.Molecular Cancer Therapeutics|August 25, 2011
Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancerNate N Waldron, Dan S Kaufman, Seunguk Oh, et al.Pageof 6